Marie-Louise is an associate director in the corporate team who specializes in corporate M&A transactions, investment rounds, joint ventures and corporate advice. She regularly assists investors and investment funds, international corporations as well as founders on corporate M&A with a specific focus on the Energy & Utilities, Life Science & Healthcare and Real Estate & Infrastructure sectors.

She works for a wide range of clients advising on both domestic and cross-border M&A and joint ventures, general corporate matters and corporate governance within the Energy & Utilities, Life Science & Healthcare, Real Estate & Infrastructure and Tech, Media and Comms sectors.
Prior to joining Osborne Clarke in March 2018, Marie-Louise worked at international law firm Loyens & Loeff for more than 6 years. She successfully completed the post-graduate course Mergers and Acquisitions at the Grotius Academy in 2017.

Work

MILabs

Advised the shareholders of MILabs on the sale of the company’s entire issued share capital to Rigaku Corporation, read more.

Hartree Partners

Osborne Clarke advises Hartree Partners, AGP Group and NaGa Solar on the creation of AMPYR Solar Europe - a major European solar joint venture.
Read more >

Connected Infrastructure Capital

Advised Connected Infrastructure Capital GmbH on acquisition of Dutch wind farm asset operator EWEF B.V.
Read more >

ViroClinics and Summit Partners

Advised ViroClinics Biosciences, a leading virology contract research organization, and American private equity company Summit Partners, on the acquisition of DDL Diagnostic Laboratory, read more.

Infosys

Osborne Clarke advises Infosys on the acquisition of GuideVision, read more

Terumo

Advised Terumo, a global leader in medical technology based in Tokyo, Japan on the acquisition of Quirem Medical, a Netherlands-based healthcare start-up specializing in the development of next-generation microspheres for Selective Internal Radiation Therapy (SIRT), a treatment for liver tumors, read more.

Morrison & Co

Advised Morrison & Co on its acquisition of leading Dutch fibre connectivity business.
Read more >

VarmX

Advised the syndicate of investors on VarmX’s EUR 32 million Series B financing round financing, read more.

DDL Diagnostic Laboratory

Advised ViroClinics and Summit Partners on the acquisition of DDL Diagnostic Laboratory.

Cedemo

Advised Cedemo on sale of its Toys and Entertainment Data Business to Icecat. Read more >

Oaky

Advised Oaky on $9.5M Series A financing by PeakSpan Capital, read more.

Infosys

Advised Infosys on a strategic partnership with ABN AMRO, including the acquisition of a majority-stake in Stater, read more

EQT Ventures

Advised EQT Ventures on a co-lead €20m funding round for Amsterdam-based electric scooter company Dott

NightBalance

Represented the founders, INKEF Capital, Gilde Healthcare, Thuja Capital Healthcare, Health Innovation Fund, Van Herk Ventures (sellers) in the sale of NightBalance to Royal Philips. Nightbalance is a digital health scale-up company based in the Netherlands, that has developed an innovative, easy to use device to treat positional obstructive sleep apnea and positional snoring. Read more

Ancala Partners

Advised Ancala Partners on its majority acquisition of FORE Freedom and Glasvezel Groep Nederland, read more.

Insights